Is a complete CSE/NIRV.X research report available?

No complete published report is available for cse/NIRV.X (CSE/NIRV.X) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

CSE/NIRV.X (CSE/NIRV.X)

Canadian Securities Exchange: CSE/NIRV.X · CAD

CA$0.03

+0.00 (0.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-28 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first CSE/NIRV.X analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	573.1K
Net income (ttm)	-358.6K
EPS (ttm)	-CA$0.02
Shares out	22.9M
Volume	0
Beta	-0.99

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -358.6K
EPS (ttm): -CA$0.02
Market cap: 573.1K

All CSE/NIRV.X indicators

Market & fundamental data

Available fields

127

Groups with data

Currency

CAD

Showing 127 of 127 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Employees Change	0%
Employees Change Percent	0
Enterprise value	CAD 708,612
Exchange	Canadian Securities Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-07-28
Market cap	CAD 573,083
Price	CAD 0.03
Price currency	CAD
Sic	2834
Symbol	cse/NIRV.X
Website	https://nirvanalifescience.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-62.58%
FCF yield	-153.61%
P/B ratio	-0.81x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	CAD -358,633
ROA	-1,018.4
ROCE	53.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-75.02%
Cagr3y	-58.5%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	CAD 20,319
Cash	CAD 1,347
Current Assets	CAD 20,319
Current Liabilities	CAD 643,266
Debt	CAD 142,173
Debt FCF	CAD -0.16
Equity	CAD -709,221
Interest Coverage	-166
Liabilities	CAD 729,540
Long Term Assets	CAD 0
Long Term Liabilities	CAD 86,274
Net Cash	CAD -140,826
Net Cash By Market Cap	CAD -24.57
Tangible Book Value	CAD -703,921
Tangible Book Value Per Share	CAD -0.03
WACC	-0.72

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.03
Net Working Capital	CAD -482,121
Quick ratio	0.03
Working Capital	CAD -622,947

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	38.43%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-75%
200-day SMA	0.46
3Y total return	-92.86%
50-day SMA	0.16
50-day SMA vs 200-day SMA	50under200
All Time High	9.5
All Time High Change	-99.74%
All Time High Date	2022-03-22
All Time Low	0.01
All Time Low Change	400%
All Time Low Date	2026-02-25
ATR	0.03
Beta	-0.99
Beta1y	-7.73
Beta2y	-3.25
Ch YTD	-66.67
High	0.03
High52	0.14
High52 Date	2025-10-10
High52ch	-82.14%
Low	0.03
Low52	0.01
Low52 Date	2026-04-23
Low52ch	400%
Ma50ch	-84.16%
Price vs 200-day SMA	-94.51%
RSI	43.6
RSI Monthly	31.67
RSI Weekly	41.21
Sharpe ratio	2.21x
Sortino ratio	7.98
Total Return	38.43%
Tr YTD	-66.67
Tr1m	150%
Tr1w	-50%
Tr3m	400%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -332,059

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	18,418,888%
Net Borrowing	56,046
Shares Insiders	11.91%
Shares Out	22,923,301
Shares Qo Q	-0.48%
Shares Yo Y	-38.43%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD -895,445
Adjusted OCF	-895,445
Average Volume	6,663.9x
Bv Per Share	-0.03
Ch1m	150
Ch1w	-50
Ch1y	-75
Ch3m	400
Ch3y	-92.86
Ch6m	-66.67
Change	0%
Change From Open	0
Close	0.03
Days Gap	0
Earnings Date	2026-09-04
EBIT	CAD -332,059
EPS	CAD -0.02
F Score	1
FCF	CAD -880,322
FCF EV Yield	-124.23x
FCF Per Share	CAD -0.04
Financing CF	1,006,464
Fiscal Year End	April
Is Primary Listing	1
Last Report Date	2026-01-31
Last Split Date	2025-03-24
Last Split Type	Reverse
Ma150	0.32
Ma150ch	-92.15%
Ma20	0.05
Ma20ch	-53.1%
Net CF	8,789
Next Earnings Date	2026-09-04
Open	0.03
Price Date	2026-07-24
Relative Volume	0.74x
Share Based Comp	15,123
Tr6m	-66.67%
Volume	0

CSE/NIRV.X (CSE/NIRV.X)

Coverage state: Market snapshot only — no published research

Generate the first CSE/NIRV.X analysis

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/NIRV.X

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/NIRV.X indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on CSE/NIRV.X

Frequently asked questions